This article investigates the introduction of the Huntington’s Disease Integrated Staging System (HD-ISS) in research ...
Although the phase 2b study of SOM3355 for HD-associated chorea missed its primary endpoint, participants not taking ...
Columnist Tanita Allen's mindfulness and meditation practice has taught her that she doesn't need to fight herself every ...
Deutetrabenazine significantly reduced chorea severity over 16 weeks in a prospective study of Chinese adults with Huntington disease (HD).
In 12 high-dose patients at 48 months, both cUHDRS and TFC continued to demonstrate meaningful slowing of disease progression and clear dose-dependent response; the primary endpoint of cUHDRS showed ...
Neurocrine Biosciences, Inc. ( NBIX) announced that Eiry W. Roberts will return as Chief Medical Officer, effective immediately, succeeding Sanjay Keswani, who will depart the company by mutual ...
Original article here 💁♂️ Also worth reading 💁♂️ "My body moves on its own against my will""It's become harder to walk than before""My body feels stiff""I don't feel calm"Huntington's disease is a ...
Unique research highlights an overlooked mental health disparity among Indigenous North American people with HD – and the ...
Participants gather at the HDSA Michigan Chapter's Team Hope Walk in Royal Oak to raise awareness and funds for Huntington's disease research. (WDIV) ROYAL OAK, Mich. – Families affected by Huntington ...
Huntington's disease is a hereditary neurodegenerative disorder caused by an autosomal dominant mutation. The hallmark symptom of Huntington's disease is the presence of progressive chorea (abnormal ...
A new study has revealed why some people with Huntington's disease develop symptoms 10–12 years earlier and experience a more aggressive form of the disease. The research, published in the journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results